What is CAPR's current stock price?

As of now, CAPR is trading at $26.02, with a daily change of -4.27%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CAPR Stock Analysis & IQ Rating | Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc

$26.02

-$1.16 | -4.27%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$40.37

MKT CAP

$1.19B

52W Low

$4.3

VOL

$1.78M

P/E Ratio

N/A

AVG VOL

$4.51M

RSI

71.34

TREND

Uptrend

CAPR Stock IQ

Login to see Capricor Therapeutics Inc (CAPR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CAPR Target Price

Login to display

Strengths

CAPR Rewards

Upgraded on attractively valued

CAPR Rewards

Earnings are forecast to grow

CAPR Rewards

Outperform the market

CAPR Rewards

Investors confidence is positive

CAPR Price Performance

$5.69 (+357.29%)

$6.65 (+291.28%)

$6.48 (+301.54%)

$14.08 (+84.80%)

1year

6month

3month

1month

CAPR Risk Level

CAPR has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

High volatilty

Low

LOW

HIGH

CAPR Analysts Opinion

CAPR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CAPR Analysts Opinion

CAPR Analysts opinion is positive and also has improved from the past 3 months

CAPR Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

84%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

100%

CAPR Street Sentiment

CAPR Street Sentiment is extremely bullish and have positive views on the near-term outlook

CAPR Performance Sentiment

Sentiments overview associated with CAPR events and the stock performance.

84%

16%

Positive

Negative

21 out of 25
events present

4 out of 25
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$26.02

Resistance
Price

$4.60

Current Price Range

$29.96

Show methods +

CAPR Latest Analysis +

Oppenheimer Maintains Capricor Therapeutics (CAPR) Outperform Recommendation. Fintel reports that on December 8 2025 Oppenheimer maintained coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Outperform recommendation. Analyst Price Forecast Suggests 44.90% Upside

Tue Dec 9, 2025

$27.38 | -4.13%

Potential

Rating

Martin Shkrelis Biotech Short Position Is Blowing Up As Stock Soars 440%: Momentum Score Spikes. Investor over the past week following a major clinical catalyst. Popularly known as “.Pharma bro”. Shkreli initiated a short position against California-based Capricor Therapeutics Inc. two weeks ago referring to the company’.s HOPE-3 cell therapy for Duchenne Muscular Dystrophy as “.COPE-3.”.“.It will not work. This is the company'.s only asset”. Shkreli said

Mon Dec 8, 2025

$28.56 | +6.21%

Momentum

CAPR Stock Skyrockets 282% in a Week: Heres What You Need to Know. Capricor Therapeutics stock soars after meeting key goals with statistical significance in a phase III study of deramiocel for Duchenne cardiomyopathy.

Fri Dec 5, 2025

$26.89 | +5.87%

Momentum

Capricor Therapeutics prices $150M stock offering.

Fri Dec 5, 2025

$26.89 | +5.87%

Activity

Maxim Group Maintains Capricor Therapeutics (CAPR) Buy Recommendation. Fintel reports that on December 4 2025 Maxim Group maintained coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Buy recommendation. Analyst Price Forecast Suggests 29.53% Downside

Fri Dec 5, 2025

$26.89 | +5.87%

Momentum

Rating

Capricor Therapeutics launches proposed public offering of common stock.

Thu Dec 4, 2025

$25.40 | -15.22%

Activity

HOPE On The Horizon For Capricor. To Submit Response To Complete Response Letter . (RTTNews) - Capricor Therapeutics Inc. (CAPR) on Wednesday reported positive topline results from its pivotal Phase 3 HOPE-3 trial of Deramiocel its investigational cell therapy for Duchenne Muscular Dystrophy (DMD).

Thu Dec 4, 2025

$25.40 | -15.22%

Activity

HC Wainwright & Co. Maintains Capricor Therapeutics (CAPR) Buy Recommendation. Fintel reports that on December 3 2025 HC Wainwright &. Co. maintained coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Buy recommendation. Analyst Price Forecast Suggests 231.98% Upside

Thu Dec 4, 2025

$25.40 | -15.22%

Rating

Capricor Stock Soars Shkreli Is Short: Heres What Pharma Bro Had To Say. ) stock soared on Wednesday after the company announced positive topline data from the Phase 3 HOPE-3 trial for its lead cell therapy candidate deramiocel.CAPR stock is soaring. See the real-time price action here.The data release and stock surge triggered a dramatic response from controversial former pharma executive and prominent short-seller had publicly bet against Capricor'.s success.Benzinga reached out to Capric

Wed Dec 3, 2025

$29.96 | +371.07%

Activity

Momentum

Wednesday Sector Leaders: Biotechnology Trucking Stocks. In trading on Wednesday biotechnology shares were relative leaders up on the day by about 4.3%. Leading the group were shares of Capricor Therapeutics up about 352.3% and shares of Beam Therapeutics up about 11.9% on the day.Also showing relative strength are trucking shar

Wed Dec 3, 2025

$29.96 | +371.07%

Potential

FAQ About CAPR Stock Insights

What is CAPR current stock price?

What are CAPR stock strengths?

What is CAPR Risk Level?

What is CAPR market cap and volume?

What is CAPR current Stock IQ?

Should I buy CAPR stock right now?

Is CAPR a Strong Buy right now?

What does a 'Strong Buy' rating mean for CAPR?

What does a 'Strong Sell' rating mean for CAPR?

What factors influence CAPR's Stock IQ?

Explore our CAPR Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CAPR Stock Strategies
Effective Risk Management

FIND US ON

Receive our CAPR Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CAPR

Capricor Therapeutics Inc

Current Price

$26.02

-$1.16 | -4.27%

52W High

$40.37

MKT CAP

$1.19B

52W Low

$4.3

VOL

$1.78M

P/E Ratio

N/A

AVG VOL

$4.51M

RSI

71.34

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CAPR Rewards

Upgraded on attractively valued

CAPR Rewards

Earnings are forecast to grow

CAPR Rewards

Outperform the market

CAPR Rewards

Investors confidence is positive

CAPR Price Performance

$5.69 (+357.29%)

$6.65 (+291.28%)

$6.48 (+301.54%)

$14.08 (+84.80%)

1year

6month

3month

1month

CAPR Analysts Opinion

CAPR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CAPR Analysts Opinion

CAPR Analysts opinion is positive and also has improved from the past 3 months

CAPR Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

84%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

100%

CAPR Street Sentiment

CAPR Street Sentiment is extremely bullish and have positive views on the near-term outlook

CAPR Risk Level

CAPR has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

High volatilty

Low

LOW

HIGH

CAPR Performance Sentiment

Sentiments overview associated with CAPR events and the stock performance.

84%

16%

Positive

Negative

21 out of 25
events present

4 out of 25
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$26.02

Resistance
Price

$4.60

Current Price Range

$29.96

Show methods +

CAPR Stock IQ

Login to unlock Capricor Therapeutics Inc (CAPR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CAPR Latest Analysis

Oppenheimer Maintains Capricor Therapeutics (CAPR) Outperform Recommendation. Fintel reports that on December 8 2025 Oppenheimer maintained coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Outperform recommendation. Analyst Price Forecast Suggests 44.90% Upside

Tue Dec 9, 2025

$27.38 | -4.13%

Potential

Rating

Martin Shkrelis Biotech Short Position Is Blowing Up As Stock Soars 440%: Momentum Score Spikes. Investor over the past week following a major clinical catalyst. Popularly known as “.Pharma bro”. Shkreli initiated a short position against California-based Capricor Therapeutics Inc. two weeks ago referring to the company’.s HOPE-3 cell therapy for Duchenne Muscular Dystrophy as “.COPE-3.”.“.It will not work. This is the company'.s only asset”. Shkreli said

Mon Dec 8, 2025

$28.56 | +6.21%

Momentum

CAPR Stock Skyrockets 282% in a Week: Heres What You Need to Know. Capricor Therapeutics stock soars after meeting key goals with statistical significance in a phase III study of deramiocel for Duchenne cardiomyopathy.

Fri Dec 5, 2025

$26.89 | +5.87%

Momentum

Capricor Therapeutics prices $150M stock offering.

Fri Dec 5, 2025

$26.89 | +5.87%

Activity

Maxim Group Maintains Capricor Therapeutics (CAPR) Buy Recommendation. Fintel reports that on December 4 2025 Maxim Group maintained coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Buy recommendation. Analyst Price Forecast Suggests 29.53% Downside

Fri Dec 5, 2025

$26.89 | +5.87%

Momentum

Rating

Capricor Therapeutics launches proposed public offering of common stock.

Thu Dec 4, 2025

$25.40 | -15.22%

Activity

HOPE On The Horizon For Capricor. To Submit Response To Complete Response Letter . (RTTNews) - Capricor Therapeutics Inc. (CAPR) on Wednesday reported positive topline results from its pivotal Phase 3 HOPE-3 trial of Deramiocel its investigational cell therapy for Duchenne Muscular Dystrophy (DMD).

Thu Dec 4, 2025

$25.40 | -15.22%

Activity

HC Wainwright & Co. Maintains Capricor Therapeutics (CAPR) Buy Recommendation. Fintel reports that on December 3 2025 HC Wainwright &. Co. maintained coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Buy recommendation. Analyst Price Forecast Suggests 231.98% Upside

Thu Dec 4, 2025

$25.40 | -15.22%

Rating

Capricor Stock Soars Shkreli Is Short: Heres What Pharma Bro Had To Say. ) stock soared on Wednesday after the company announced positive topline data from the Phase 3 HOPE-3 trial for its lead cell therapy candidate deramiocel.CAPR stock is soaring. See the real-time price action here.The data release and stock surge triggered a dramatic response from controversial former pharma executive and prominent short-seller had publicly bet against Capricor'.s success.Benzinga reached out to Capric

Wed Dec 3, 2025

$29.96 | +371.07%

Activity

Momentum

Wednesday Sector Leaders: Biotechnology Trucking Stocks. In trading on Wednesday biotechnology shares were relative leaders up on the day by about 4.3%. Leading the group were shares of Capricor Therapeutics up about 352.3% and shares of Beam Therapeutics up about 11.9% on the day.Also showing relative strength are trucking shar

Wed Dec 3, 2025

$29.96 | +371.07%

Potential

Discover CAPR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CAPR. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CAPR Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CAPR Stock trends

CAPR Stock performance

CAPR Stock analysis

CAPR investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CAPR

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CAPR

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

CAPR Stock Analysis & IQ Rating | Capricor Therapeutics Inc.

CAPR Stock IQ

CAPR Target Price

CAPR Risk Level

CAPR Analysts Opinion

CAPR Street Sentiment

CAPR Performance Sentiment

Technical Price Levels

Explore our CAPR Stock insights

Receive our CAPR Daily Alerts

CAPR Street Sentiment

CAPR Risk Level

Technical Price Levels

Discover CAPR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CAPR. We're here to help you make informed investment decisions today.

Receive our CAPR Daily Alerts

CAPR Runner Alarm